HIGHLIGHTS
- who: Mohamed A. Yassin from the University of Saskatchewan, Canada have published the research: Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients, in the Journal: (JOURNAL)
- what: The aim of this study is to confirm the efficacy of Lglutamine therapy in both pediatric and adult patients with SCD at follow-up time points of 24, 48 and 72 weeks. This study provides the description of real-world data on L-glutamine therapy in patients with SCD supporting the previously published results .
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.